Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Multiple Sclerosis, Chronic Progressive

Known as: Chronic Progressive Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive [Disease/Finding] 
A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing… Expand
National Institutes of Health

Related topics

Related topics

10 relations
In BloodMicrobiologicalchemically inducednursing therapy
Expand

Broader (1)

Multiple Sclerosis

Narrower (3)

Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Progressive RelapsingMultiple Sclerosis, Secondary Progressive

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
High doses of biotin in chronic progressive multiple sclerosis: a pilot study.
BACKGROUND No drug has been found to have any impact on progressive multiple sclerosis (MS). Biotin is a vitamin acting as a… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
1999
Highly Cited
1999
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
In experimental animal models of multiple sclerosis demyelinating antibody responses are directed against the myelin… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
1996
Highly Cited
1996
The treatment of chronic progressive multiple sclerosis with cladribine.
A 2-year, placebo-controlled, double-blind, crossover study was started in 1992 to evaluate cladribine, an immunosuppressive drug… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
1995
Highly Cited
1995
Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis
A randomized, double‐blinded, placebo‐controlled, clinical trial of low‐dose, weekly, oral methotrexate was performed in 60… Expand
Highly Cited
1994
Highly Cited
1994
Cladribine in treatment of chronic progressive multiple sclerosis
Chronic progressive multiple sclerosis (MS) is a severely disabling demyelinating disease in which autoimmune processes seem to… Expand
Highly Cited
1993
Highly Cited
1993
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis
Magnetic resonance imaging is a highly sensitive method for the detection of the lesions of multiple sclerosis and renders… Expand
Highly Cited
1991
Highly Cited
1991
Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
BACKGROUND Cachectin, or tumor necrosis factor-alpha (TNF-alpha), is a principal mediator of the inflammatory response and may be… Expand
Highly Cited
1990
Highly Cited
1990
Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trial
Patients with clinically definite multiple sclerosis, mild to moderately severe neurological disability (entry score on the… Expand
Highly Cited
1984
Highly Cited
1984
Memory disturbance in chronic progressive multiple sclerosis.
Forty-four patients with chronic progressive multiple sclerosis (MS) were compared with age- and education-matched control groups… Expand
Review
1983
Review
1983
Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis
In an analysis of pooled data, we have found that cytotoxic-suppressor T cells outnumber the helper-inducer subset and also the… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE